Vertex Pharmaceuticals (United States)
In research, Vertex Pharmaceuticals (United States) stands highest in Medicine (#4,294 of 10,443 worldwide) and Health Sciences (#5,637 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #9,345 of 28,054 · #3,359 all time
- Rank in United States
- #1,246 of 4,192
- Research works
- 1k ▼ 21% vs 2013–17
- Citations
- 61k 58.5 per fractional work
- Top-10% rate
- 19.3% record average 16.5%
- Open access
- 36% world 28%
What is Vertex Pharmaceuticals (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,294 of 10,443 | 18.1% | 72 | #2306 | |
| Health SciencesDomain | #5,637 of 11,982 | 18.5% | 76 | #2994 |
Each strip is that field’s whole ranked pool, with the notch where Vertex Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 3.8×. Every wedge is a field page.
- Mathematics 3.8×
- Pharmacology, Toxicology and Pharmaceutics 3.2×
- Medicine 2.7×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Immunology and Microbiology 1.9×
- Chemistry 1.8×
- Veterinary 1.4×
- Economics, Econometrics and Finance 1.2×
- Decision Sciences 1.0×
- Health Professions 0.9×
- Neuroscience 0.9×
- Engineering 0.5×
- Materials Science 0.5×
- Computer Science 0.4×
- Physics and Astronomy 0.3×
- Psychology 0.3×
- Social Sciences 0.3×
- Environmental Science 0.3×
- Dentistry 0.2×
- Chemical Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Business, Management and Accounting 0.1×
- Nursing 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Vertex Pharmaceuticals (United States)?
Ranked on the composite score, Nanxin Li, David J. Livingston and Samuel M. Moskowitz lead among researchers whose main affiliation is Vertex Pharmaceuticals (United States).
- 1 Nanxin Li United States · #120,417 worldwide 222 citations · 28 works
- 2 David J. Livingston United States · #153,260 worldwide 341 citations · 21 works
- 3 Samuel M. Moskowitz United States · #175,277 worldwide 398 citations · 18 works
- 4 Mark A. Murcko United States · #177,550 worldwide 419 citations · 18 works
- 5 Mark Fleming United States · #220,051 worldwide 758 citations · 16 works
- 6 Nitin Nair United States · #294,425 worldwide 297 citations · 15 works
- 7 Keith P. Wilson United States · #307,167 worldwide 213 citations · 16 works
- 8 Fredrick Van Goor United States · #320,085 worldwide 103 citations · 16 works
- 9 Sarah Robertson United States · #425,567 worldwide 77 citations · 16 works
- 10 Mark Higgins United States · #528,314 worldwide 46 citations · 17 works
Which keywords describe research at Vertex Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Pulmonary Hypertension, Genetic Regulation, Sickle-cell Disease, Thalassemia, Epidemiology, Cystic Fibrosis, Pulmonary Infections and Bronchiectasis.
- Health Utility Measures
- Infection Control Measures
- Hematopoietic Stem Cells
- Continuous Glucose Monitoring
- Blood Groups
- Prognostic Factors
- Pancreatic Cancer
- Adaptive Designs
- Insulin Therapy
- Type 1 Diabetes
- Glomerular Diseases
- Iron Deficiency
- Bayesian Methods
- Quality of Life
- Cardiovascular Disease
- Inflammation
- CFTR
- Cystic Fibrosis
- Sickle-cell Disease
- Pulmonary Hypertension
- Epidemiology
- Genetic Regulation
- Thalassemia
- Bronchiectasis
- Pulmonary Infections
- Anemia
- Oxidative Stress
- Biomarkers
- Glycemic Control
- Diabetes
- Nephrotic Syndrome
- Hepcidin
- Iron Regulation
- False Discovery Rate
- Health Promotion
- Alloimmunization
- Complications
- Hypoglycemia
- Child Care
- Cost-effectiveness Analysis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology22▲ 3.9×24 topics
- Pulmonary Hypertension16▲ 82×3 topics
- Genetic Regulation16▲ 69×3 topics
- Sickle-cell Disease16▲ 262×1 topic
- Thalassemia16▲ 262×1 topic
- Cystic Fibrosis10▲ 106×2 topics
- Bronchiectasis10▲ 255×1 topic
- CFTR10▲ 255×1 topic
- Pulmonary Infections10▲ 129×2 topics
- Inflammation8▲ 2.7×30 topics
- Anemia6▲ 47×4 topics
- Cardiovascular Disease6▲ 3.6×14 topics
- Oxidative Stress5▲ 2.2×16 topics
- Quality of Life4▲ 2.2×8 topics
- Biomarkers4▲ 3.9×7 topics
- Bayesian Methods4▲ 51×2 topics
- Glycemic Control4▲ 16×4 topics
- Iron Deficiency3▲ 45×2 topics
- Diabetes3▲ 4.5×6 topics
- Glomerular Diseases3▲ 67×1 topic
- Nephrotic Syndrome3▲ 67×1 topic
- Type 1 Diabetes3▲ 26×2 topics
- Hepcidin3▲ 55×1 topic
- Insulin Therapy3▲ 18×3 topics
- Iron Regulation3▲ 55×1 topic
- Adaptive Designs3▲ 95×1 topic
- False Discovery Rate3▲ 95×1 topic
- Pancreatic Cancer3▲ 18×2 topics
- Health Promotion3▲ 5.7×4 topics
- Prognostic Factors3▲ 4.2×3 topics
- Alloimmunization2▲ 74×1 topic
- Blood Groups2▲ 74×1 topic
- Complications2▲ 3.4×2 topics
- Continuous Glucose Monitoring2▲ 36×1 topic
- Hypoglycemia2▲ 36×1 topic
- Hematopoietic Stem Cells2▲ 19×3 topics
- Child Care2▲ 48×1 topic
- Infection Control Measures2▲ 48×1 topic
- Cost-effectiveness Analysis2▲ 14×1 topic
- Health Utility Measures2▲ 14×1 topic
Which research topics does Vertex Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Cystic Fibrosis Research Advances, Renal Diseases and Glomerulopathies and Iron Metabolism and Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 16 works
- 2 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 10 works
- 3 Renal Diseases and Glomerulopathies Nephrology 3 works
- 4 Iron Metabolism and Disorders Hematology 3 works
- 5 Statistical Methods in Clinical Trials Statistics and Probability 3 works
- 6 Blood groups and transfusion Hematology 2 works
- 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
- 8 Pediatric health and respiratory diseases Emergency Medical Services 2 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 10 Acute Myeloid Leukemia Research Hematology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Vertex Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 21% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.